Herbalife
187 hedge funds and large institutions have $784M invested in Herbalife in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 27 closing their positions.
26% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 27
4% more funds holding
Funds holding: 180 → 187 (+7)
5% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 60
2.51% less ownership
Funds ownership: 110.68% → 108.17% (-2.5%)
32% less capital invested
Capital invested by funds: $1.15B → $784M (-$368M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
76% less call options, than puts
Call options by funds: $20.9M | Put options by funds: $87.4M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$20.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$11M |
| 3 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$8.65M |
| 4 |
WPL
WINDACRE PARTNERSHIP LLC
Houston,
Texas
|
-$6.76M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.63M |
HLF Hedge Fund Activity: Q3 2024 in Review
187 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Herbalife (HLF) for Q3 2024, worth a combined $784M — down 32% from $1.15B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new HLF positions and 27 closed out — a net gain of 7 holders — while 63 added to existing stakes and 60 trimmed.
The largest buyer was LSV Asset Management, adding an estimated $14.9M. The largest seller was Morgan Stanley, cutting an estimated $20.7M.
- 187 institutional investors held Herbalife (HLF) as of Q3 2024, up from 180 in Q2 2024.
- Funds reported $784M of Herbalife stock for Q3 2024, down 32% quarter-over-quarter.
- 34 funds opened new Herbalife positions in Q3 2024 and 27 closed out, a net change of +7 holders.
- The largest Herbalife buyer in Q3 2024 was LSV Asset Management, an estimated $14.9M added.
- The largest Herbalife seller in Q3 2024 was Morgan Stanley, an estimated $20.7M sold.
Based on aggregated 13F filings for Q3 2024.